Research cutoff: September 13, 2026. Dollar amounts are USD per common share unless stated otherwise. This guide separates declared payments, calculations and unannounced future decisions.
Pfizer’s verified quarterly cash dividend is $0.43 per share. Its three listed 2026 payments total $1.29. Four unchanged payments would equal $1.72 in a 2027 scenario; that figure is not a guaranteed annual payout or evidence of a new stock split.
Pfizer dividend dates in calendar 2026
Pfizer’s official dividend and split history identifies the following cash distributions. The table distinguishes ex-dates from payable dates, an important difference for anyone tracing eligibility and broker cash credits.
On a small screen, swipe the table horizontally. Keyboard users can focus the table region and use the arrow keys.
| Ex-date | Record date | Payable date | Per share |
|---|---|---|---|
| January 23, 2026 | January 23, 2026 | March 6, 2026 | $0.43 |
| May 8, 2026 | May 8, 2026 | June 12, 2026 | $0.43 |
| July 24, 2026 | July 24, 2026 | September 1, 2026 | $0.43 |
For 100 eligible shares, each payment corresponds to $43 gross and the three together to $129. The annualized figure is $172 for those same 100 shares if four equal payments are assumed. We have not added an unannounced fourth 2026 distribution to the verified ledger. Use actual declarations when reconciling an account, not a website’s forward annual-dividend field.
What would change Pfizer’s 2027 income?
On a small screen, swipe the table horizontally. Keyboard users can focus the table region and use the arrow keys.
| Assumed payments | Annual per share | 100 eligible shares |
|---|---|---|
| Four × $0.43 | $1.72 | $172 |
| Four × hypothetical $0.44 | $1.76 | $176 |
| Three × $0.43, final × hypothetical $0.44 | $1.73 | $173 |
| Four × hypothetical $0.35 | $1.40 | $140 |
The one-cent increase and lower-rate case are chosen for sensitivity analysis. They are not attributed to Pfizer or to analysts. Timing changes annual cash: reaching 44 cents only at the final payment produces one extra dollar for 100 shares, while four payments at that rate produce four extra dollars. No 2027 date is marked confirmed in this guide.
A dividend review built around the product portfolio
Our Pfizer framework asks whether recurring business cash supports distributions after the spending needed to sustain future products. A pharmaceutical company faces research costs before knowing which projects will become durable sellers. Commercial launches, competition and changes in product mix can affect cash generation differently from headline revenue. Avoid treating a single successful announcement as a new stream of immediately distributable cash.
Review the full cash-flow statement alongside reported and adjusted earnings. Acquisition-related accounting can make earnings measures diverge, while debt repayments and development commitments still require cash. Use matching periods for dividends and the denominator of a coverage calculation. A quarterly payout divided by annual earnings, or annual dividends divided by one quarter’s cash flow, can create a ratio that looks precise but is not comparable.
A high dividend yield can carry substantial price risk
At an illustrative $25 share price, $1.72 corresponds to a 6.88% indicated yield. This example is neither a current quote nor a target. A high ratio can reflect a low market price as well as a large dividend. It therefore requires a review of business expectations and distribution capacity, not an assumption that income is unusually safe.
An investor comparing two income stocks should keep tax treatment, concentration and cash timing separate from the headline yield. Dividend cash does not protect principal. If the share price loses more than the annual distribution, total return can remain negative even when every announced payment is made. Reinvestment also buys at future market prices, so it cannot be modeled as free additional return.
What Pfizer’s historical stock splits actually show
The issuer’s historical table includes a 3-for-1 split with a June 30, 1999 payable date and July 1 ex-date, and earlier 2-for-1 actions. These are historical corporate events. This guide verifies no new 2026 or 2027 split or bonus-share entitlement and does not forecast one from the current share price.
A 3-for-1 split changes 100 shares into 300 and divides the theoretical per-share value by three before trading effects. It does not triple total wealth. Compare historical per-share dividends on a consistent adjusted basis, and distinguish a share split from a spin-off, an employee stock award or shares bought through dividend reinvestment.
Frequently asked questions
Is $1.72 Pfizer’s confirmed 2027 dividend?
No. It assumes four future payments at the verified 43-cent rate.
Can an old split date predict the next split?
No. A new event requires its own official terms, ratio and dates. Historical frequency establishes no entitlement.
Continue your research
Read our stock-split research for the wider business context, or compare our September dividend research. A dividend is one part of total return, not protection against a fall in the share price.
LiveTodayStock editorial research. Educational information, not personalized investment advice. Cash examples are gross, exclude taxes and fees, and assume the specified shares qualified for each distribution. Future dividends require board approval.